Rankings
▼
Calendar
CTKB Q2 2020 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
CTKB
Cytek Biosciences, Inc.
$523M
Q2 2020 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$19M
Gross Profit
$8M
43.2% margin
Operating Income
-$218,000
-1.1% margin
Net Income
$8M
42.4% margin
EPS (Diluted)
$0.06
QoQ Revenue Growth
+6.4%
Cash Flow
Operating Cash Flow
-$121,000
Free Cash Flow
-$643,000
Stock-Based Comp.
$109,000
← FY 2020
All Quarters
Q3 2020 →